New 2D black phosphorus (bP)-phthalocyanine (Pc) nanohybrids have been synthesized by liquid phase exfoliation of black phosphorus crystals in the presence of two organic dyes: phthalocyanine (Pc) and manganese phthalocyanine (MnPc). The key role of the metal cation in the interfacial interaction between the organic dye and bP nanosheets was demonstrated by X-ray absorption spectroscopy and associated with an electron transfer between the metal cation Mn and bP nanosheets, which resembles a coordinative chemical bond. On the other hand, the interaction between bP nanosheets and pure phthalocyanine is governed by van der Waals forces.
View Article and Find Full Text PDFGreen chemistry emphasizes the isolation of biologically active compounds from plants and biomass to produce renewable, bio-based products and materials through sustainability and circularity-driven innovation processes. In this work, we have investigated the extraction of rosmarinic acid (RA), a phenolic acid with several biological properties, from aromatic herbs using ultrasounds and low environmental risk natural deep eutectic solvents (NADES). Various solvent mixtures have been investigated, and the parameters influencing the process have been studied by a mixture-process experimental design to identify the optimal RA extraction conditions.
View Article and Find Full Text PDFIn this study, we have developed innovative polymer nanocomposites by integrating magnesium-aluminum layered double hydroxide (LDH)-based nanocarriers modified with functional molecules into a fully biobased poly(lactic acid)/poly(butylene succinate-co-adipate) (PLA/PBSA) matrix. These LDH-based hybrid host-guest systems contain bioactive compounds like rosmarinic acid, ferulic acid, and glycyrrhetinic acid, known for their antioxidant, antimicrobial, and anti-inflammatory properties. The bioactive molecules can be gradually released from the nanocarriers over time, allowing for sustained and controlled delivery in various applications, such as active packaging or cosmetics.
View Article and Find Full Text PDFThe sodium-glucose co-transporter 2 (SGLT2) inhibitors have been shown to reduce risks of clinical events in patients with heart failure (HF), with early and sustained benefits regardless of ejection fraction, diabetic status, and care setting. As part and parcel of the modern foundational HF therapy, clinicians should be familiar with these drugs, in order to implement their use and limit the potential adverse effects. We present an up-to-date review of current evidence and a practical guide for the prescription of SGLT2 inhibitors in patients with HF, highlighting important elements for patient selection, treatment initiation, dosing, and problem solving.
View Article and Find Full Text PDFHeart failure (HF) is one of the main causes of morbidity in the world and is responsible for an enormous amount of health costs, mostly due to hospitalizations. The remote control techniques of vital signs and health status have the potential to help prevent factors leading to HF instability by stimulating early therapeutic interventions. The goal of telemedicine is to change the intervention strategy from a 'reactive' type, in which therapy is optimized in response to the worsening of symptoms, to a 'pro-active' type, in which therapeutic changes are undertaken based on changes in the monitored parameters during the sub-clinical phase.
View Article and Find Full Text PDF